Masimo (MASI) Cash from Investing Activities (2009 - 2026)
Masimo's (MASI) quarterly Cash from Investing Activities came in at -$4.2 million in Q2 2026, down 139.25% year-on-year from $10.7 million in Q2 2025, and up 51.72% quarter-over-quarter from -$8.7 million in Q1 2026.
Masimo (MASI) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Masimo's Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$4.2 million for Q2 2026.
- On a quarterly basis, Cash from Investing Activities fell 139.25% year-over-year to -$4.2 million in Q2 2026; TTM through Apr 2026 was -$18.3 million, a 438.24% decrease from a year earlier, with the FY2026 full-year figure at -$3.4 million, up 86.35% from the prior year.
- Cash from Investing Activities improved to -$4.2 million in Q2 2026 per MASI's latest filing, from -$8.7 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $43.3 million in Q1 2022 and bottomed at -$1.0 billion in Q3 2022.
- The 5-year median for Cash from Investing Activities is -$8.2 million (2022), against an average of -$61.6 million.
- Across the five-year window, Cash from Investing Activities tumbled 190.91% in 2023 and jumped 242.03% in 2024, its largest moves.
- Year by year, Cash from Investing Activities stood at -$22.8 million in 2022, then jumped by 69.74% to -$6.9 million in 2023, then soared by 242.03% to $9.8 million in 2024, then plunged by 154.08% to -$5.3 million in 2025, then grew by 20.75% to -$4.2 million in 2026.
- Per Business Quant, the three latest MASI Cash from Investing Activities figures stand at -$4.2 million (Q2 2026), -$8.7 million (Q1 2026), and -$5.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | -4.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -4.20 Mn |
| Apr 4, 2026 | -4.20 Mn |
| Jan 3, 2026 | -8.70 Mn |
| Jan 3, 2026 | -8.70 Mn |
| Sep 27, 2025 | -5.30 Mn |
| Sep 27, 2025 | -5.30 Mn |
| Jun 28, 2025 | -100,000.00 |
| Jun 28, 2025 | -100,000.00 |
| Mar 29, 2025 | 10.70 Mn |
| Mar 29, 2025 | 10.70 Mn |
| Dec 28, 2024 | 9.80 Mn |
| Dec 28, 2024 | 9.80 Mn |
| Sep 28, 2024 | -26.60 Mn |
| Sep 28, 2024 | -26.60 Mn |
| Jun 29, 2024 | 2.70 Mn |
| Jun 29, 2024 | 2.70 Mn |
| Mar 30, 2024 | -10.80 Mn |
| Mar 30, 2024 | -10.80 Mn |
| Dec 30, 2023 | -6.90 Mn |
| Dec 30, 2023 | -6.90 Mn |